Freelite® Human Kappa Free kit for use on the SPAPLUS For in vitro diagnostic use Product code: LK016.L.S
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance - ScienceDirect
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines
Binding Site | What is Freelite
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Freelite® & Hevylite®
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma | Leukemia
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
PDF) Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney diesease on haemolysis
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)
Serum free light chains in clinical laboratory diagnostics - ScienceDirect
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Freelite® & Hevylite®
Freelite® & Hevylite®
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology and the Internat
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation | Haematologica